Abstract
Abstract
Background
Pancreatic neuroendocrine tumors (PNET) account for less than 2% of all pancreatic tumors, while cystic PNETs account for only 10–18% of all resected PNETs. The most common site for metastasis is the liver. Few detailed guidelines currently exist for management of stage 4 cystic PNETs. This is a unique case that was managed with complete surgical resection in one sitting.
Case presentation
Our report is on a young male patient who was initially misdiagnosed as having a pancreatic pseudocyst and treated accordingly. He was finally diagnosed with PNET but was reluctant to undergo surgery until he developed bilobar hepatic metastasis. We performed a pylorus-preserving pancreaticoduodenectomy with a Roux-en-Y hepaticojejunostomy and wedge resection of both hepatic metastatic deposits.
Conclusion
Cystic PNETs are rare and commonly misdiagnosed as pancreatic pseudocysts. Surgical resection is considered ideal, but sparse literature exists on the management due to a paucity of cases. We have reported this case as it was successfully managed with single-stage surgery for both the primary tumor as well as bilobar hepatic metastatic deposits, and no similar cases have been reported in literature. The follow-up scan revealed no residual disease.
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. McKenna LR, Edil BH (2014) Update on pancreatic neuroendocrine tumors. Gland Surg 3(4):258–275. https://doi.org/10.3978/j.issn.2227-684X.2014.06.03.PMID:25493258;PMCID:PMC4244504
2. He CB, Zhang Y, Cai ZY, Lin XJ (2019) The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis. Endocr Connect 8(3):239–251. https://doi.org/10.1530/EC-18-0485.PMID:30726772;PMCID:PMC6391902
3. Pușcașu CI, Rimbaş M, Mateescu RB, Larghi A, Cauni V (2022) Advances in the diagnosis of pancreatic cystic lesions. Diagnostics 12(8):1779. https://doi.org/10.3390/diagnostics12081779
4. Lévy P, Rebours V (2015) Differential diagnosis of cystic pancreatic lesions including the usefulness of biomarkers. Viszeralmedizin 31(1):7–13. https://doi.org/10.1159/000371786.PMID:26285674;PMCID:PMC4433139
5. Carr RA, Bletsis P, Roch AM, House MG, Zyromski NJ, Nakeeb A, et al (2019) Cystic pancreatic neuroendocrine tumors: a more favorable lesion? Pancreatology 19(2):372–6. Available from: https://reader.elsevier.com/reader/sd/pii/S1424390319300171?token=327AB3DAEE428F5FE6F09BCA6C31C0EB58F377E557D3BE1F6D2D296B422A1CBB482A52ED15462053E787D42D76B9B7F2&originRegion=eu-west-1&originCreation=20210424120600